Literature DB >> 2986975

Catalytic properties of a human cytomegalovirus-induced protein kinase.

S Michelson, M Tardy-Panit, O Bârzu.   

Abstract

Human cytomegalovirus, a DNA virus whose genome contains a fragment of transforming DNA, induces a threonine-serine protein kinase having a molecular mass of 68 kDa (p68). p68 was extracted from cells 96-144 h after infection, and immunoprecipitated with a monoclonal antibody (F6b). Antibody-enzyme complexes were immobilized on heat/formaldehyde-inactivated Staphylococcus aureus. The best substrates for p68 were acidic proteins, phosvitin and casein. Glycogen synthase, phosphorylase alpha and histones were phosphorylated at rates not higher than 1-4% that obtained with phosvitin as substrate. ATP and GTP were equally good substrates of p68. p68 is able to autophosphorylate at the same residues (i.e. threonine and serine) as the protein substrates. Autophosphorylation does not seem to represent an intermediate in substrate phosphorylation. The protein kinase activity of p68 was not enhanced by cAMP, calcium ions, or polyamines like spermine or spermidine. Only at low Mg2+ concentration spermine enhanced by 68% the rate of casein phosphorylation. Heparin, a potent inhibitor of casein kinase II, inhibits p68 activity too, but ten-times higher concentrations were required for the same degree of inhibition. Quercetin, a bioflavonoid, acts as a strong inhibitor of p68 protein kinase activity. The inhibitory effect of quercetin was competitive towards the nucleotide substrate (Ki = 2.8 microM), and non-competitive towards the protein substrate (Ki = 15 microM).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986975     DOI: 10.1111/j.1432-1033.1985.tb08938.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Molecular characterization of the guinea pig cytomegalovirus UL83 (pp65) protein homolog.

Authors:  M R Schleiss; A McGregor; N J Jensen; G Erdem; L Aktan
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A.

Authors:  S Michelson; P Turowski; L Picard; J Goris; M P Landini; A Topilko; B Hemmings; C Bessia; A Garcia; J L Virelizier
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

3.  Rapid diagnosis of cytomegalovirus by indirect immunofluorescence assay with monoclonal antibody F6b in a commercially available kit.

Authors:  G Lucas; J M Seigneurin; J Tamalet; S Michelson; M Baccard; J F Delagneau; P Deletoille
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

4.  Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus.

Authors:  C Roby; W Gibson
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

5.  Properties of poliovirus associated protein kinase.

Authors:  M Lackmann; C Ueckermann; K Engelmann; G Koch
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines.

Authors:  Z He; Y S He; Y Kim; L Chu; C Ohmstede; K K Biron; D M Coen
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Poliovirus-associated protein kinase: destabilization of the virus capsid and stimulation of the phosphorylation reaction by Zn2+.

Authors:  M Ratka; M Lackmann; C Ueckermann; U Karlins; G Koch
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

8.  Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2.

Authors:  N Y Harel; J C Alwine
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix protein.

Authors:  A Gallina; L Simoncini; S Garbelli; E Percivalle; G Pedrali-Noy; K S Lee; R L Erikson; B Plachter; G Gerna; G Milanesi
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.